| Characteristic | Funding in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
July 2019
More information
Region
United States
Survey time period
fiscal years 2001 to 2019
Supplementary notes
* Includes malaria funding provided through USAID, CDC, NIH, and DoD. Includes base and supplemental funding. FY13 includes the effects of sequestration. FY19 is based on funding provided in the 鈥淐onsolidated Appropriations Act, 2019鈥 (P.L. 116-6) and is a preliminary estimate. Some funding for malaria programs at CDC is not yet known for FY18, FY19, and the FY20 Request and is assumed to remain at prior year levels.
Citation formats
